Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Adults with certain skin conditions may have higher levels of inflammation in their body.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Removing myelin protein zero-like 3 in mice leads to better metabolism and resistance to obesity.

The document concludes that recognizing specific histological features of different nonscarring alopecias is crucial for accurate diagnosis and understanding hair loss progression.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

People with pemphigus vulgaris and pemphigus foliaceus often have smaller sebaceous glands on their scalp.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

Aquaporins could be new drug targets for treating polycystic ovary syndrome.

The Alopecia Areata Assessment Tool (ALTO) effectively identifies alopecia areata from other hair loss types but needs more validation.

Bald men may have a lower risk of testicular cancer.

The woman's high testosterone levels indicated PCOS, leading to treatment that improved her symptoms.

The document concludes that a protein involved in hair growth may link to baldness and that more research is needed on its role in hair loss and skin cancer treatments.

The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.

A woman with acne and baldness was found to have a rare ovarian condition but successfully had a child through fertility treatment.

Ethinylestradiol/chlormadinone acetate may be an effective and well-tolerated treatment for skin conditions caused by excess androgens.

As skin ages, it gets thinner, paler, and more wrinkled, and protection and care like sunblock and moisturizers are important.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

Early treatment and weight management are important for teenagers with PCOS to reduce symptoms and long-term health risks.

Testosterone affects blood pressure control and inflammation in male rats with endotoxic shock, and blocking certain hormones may help treat it.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Anti-aging treatments like hair transplants, minoxidil, and finasteride effectively promote hair growth.

No significant hormone differences found in postmenopausal women with androgenetic alopecia.